{"info": {"author": "bars", "author_email": "barslmn@gmail.com", "bugtrack_url": null, "classifiers": ["Development Status :: 3 - Alpha", "Intended Audience :: Developers", "License :: OSI Approved :: MIT License", "Programming Language :: Python :: 3", "Topic :: Software Development :: Build Tools"], "description": "# Picus\nPointed Interpretation of Clinical Variant Significance\n\n## Quick Install\n* Linux&Mac\n\n> sudo pip3 install picus\n\n* Windows\n\n> pip install picus\n\n## Example Uses\n\n* Picus examples\n\n> picus -i input.csv -o output.json\n\n\n## Evidence Collection Process\n\n### PVS1\n* PVS1 null variant (nonsense, frameshift, canonical \u00b11 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease.\n\n#### Status\n* Implemented\n\n#### Resources\n* LoF genes list from intervar. https://raw.githubusercontent.com/barslmn/InterVar/master/intervardb/PVS1.LOF.genes.hg19\n* Null variants defined as HIGH IMPACT by https://www.ensembl.org/info/genome/variation/prediction/predicted_data.html\n\n#### Conditions\n* \"gene_symbol\" is in LoF gene list.\n* \"transcript_consequence_terms\" is high impact.\n\n#### Shortcomings\n* LoF gene list is only predictive and may be missing some actual LoF genes.\n* No checks for multiexon deletion.\n\n### PS1\n* Same amino acid change as a previously established pathogenic variant regardless of nucleotide change.\n\n#### Status\n* Implemented\n\n#### Resources\n* Clinvar xml (ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/)\n\n#### Annotation Steps\n1. Clinvar data is parsed using https://github.com/barslmn/clinvar.\n2. Sample data and clinvar data is merged based on columns \"CHR\" and \"POS\".\n3. Clinvar feature columns \"ALT\", \"hgvsp\", and \"clinical_significance\" added to original annotation.\n\n#### Conditions\n1. \"clinical_significance\" is pathogenic.\n2. Sample \"hgvsp\" and later added clinvar \"hgvsp\" changes are the same.\n3. Sample \"ALT\" and clinvar \"ALT\" are different.\n\n#### Shortcomings\n\n### PS2\n* De novo (both maternity and paternity confirmed) in a patient with the disease and no family history.\n\n#### Status\n* Not Checked\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PS3\n* Well-established\u2002in\u2002vitro\u2002or\u2002in\u2002vivo\u2002functional\u2002studies\u2002supportive\u2002of\u2002a\u2002damaging\u2002effect\u2002on\u2002the\u2002gene\u2002or\u2002gene\u2002product\n\n#### Status\n* Not Checked\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PS4\n* The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls\n\n#### Status\n* Implemented\n\n#### Resources\n* Intervar\n\n#### Conditions\n1. \"id\" is in id list.\n\n#### Shortcomings\n1. No idea how the source is made.\n\n### PM1\n* Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation\n\n#### Status\n* Planned.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PM2\n* Absent from controls (or at extremely low frequency if recessive) (Table 6) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium\n\n#### Status\n* Implemented\n\n#### Resources\n* VEP\n\n#### Conditions\n* \"gnomad\" less than 0.001.\n\n#### Shortcomings\n\n### PM3\n* For\u2002recessive\u2002disorders,\u2002detected\u2002in\u2002trans with a pathogenic variant\n\n#### Status\n* Planned for trio\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PM4\n* Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants\n\n#### Status\n* Implemented\n\n#### Resources\n* VEP\n\n#### Conditions\n* \"transcript_consequence_terms\" is \"inframe_insertion\", \"inframe_deletion\", or \"stop_lost\".\n\n#### Shortcomings\n* No checks for repeat regions.\n\n### PM5\n* Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before\n\n#### Status\n* Broken. (\u256f\u00b0\u25a1\u00b0\uff09\u256f\ufe35 \u253b\u2501\u253b)\n\n#### Resources\n* Clinvar xml (ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/)\n\n#### Annotation Steps\n1. Clinvar data is parsed using https://github.com/barslmn/clinvar.\n2. Sample data and clinvar data hgvsp columns parsed till position.\n3. Synonym changes removed from clinvar data.\n4. Clinvar feature columns \"hgvsc\", and \"clinical_significance\" added to original annotation based on protein change position.\n\n#### Conditions\n1. \"gnomad\" less then 0.001.\n2. \"clinical_significance\" is pathogenic.\n3. \"transcript_consequence_terms\" is missense variant.\n4. \"hgvsc\" of the variant and clinvar entry dont match.\n\n#### Shortcomings\n\n### PM6\n* Assumed de novo, but without confirmation of paternity and maternity\n\n#### Status\n* Planned for trio.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PP1\n* Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease\n\n#### Status\n* Planned after Vesta.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PP2\n* Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease\n\n#### Status\n* Implemented\n\n#### Resources\n* Intervar\n\n#### Conditions\n* \"transcript_consequence_terms\" is a missense variant.\n* \"gene_symbol\" is in PP2 gene list.\n\n#### Shortcomings\n\n### PP3\n* Multiple\u2002lines\u2002of\u2002computational\u2002evidence\u2002support\u2002a\u2002deleterious\u2002effect\u2002on\u2002the\u2002gene\u2002or\u2002gene\u2002product\u2002(conservation, evolutionary, splicing impact, etc.)\n\n#### Status\n* Implemented\n\n#### Resources\n* Vep\n\n#### Conditions\n* \"sift_score\" less than 0.05\n* \"polyphen_score\" greater than 0.908\n\n#### Shortcomings\n\n### PP4\n* Patient\u2019s phenotype or family history is highly specific for a disease with a single genetic etiology\n\n#### Status\n* Not Checked.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### PP5\n* Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation\n\n#### Status\n* Implemented.\n\n#### Resources\n* Clinvar\n\n#### Conditions\n* \"clinical_significance\" is Pathogenic.\n\n#### Shortcomings\n\n### Benign\n\n### BA1\n* Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium\n\n#### Status\n* Implemented.\n\n#### Resources\n* Vep\n\n#### Conditions\n* \"minor_allele_freq\" is greater than 0.05\n\nOR\n\n* \"gnomad\" is greater than 0.05.\n\n#### Shortcomings\n\n### BS1\n* Allele frequency is greater than expected for disorder\n\n#### Status\n* Planned for later.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BS2\n* Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age\n\n#### Status\n* Planned\n\n#### Resources\n* Intervar\n\n#### Conditions\n\n#### Shortcomings\n\n### BS3\n* Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing\n\n#### Status\n* Not Checked.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BS4\n* Lack of segregation in affected members of a family\n\n#### Status\n* Not Checked.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BP1\n* Missense variant in a gene for which primarily truncating variants are known to cause disease\n\n#### Status\n* Implemented.\n\n#### Resources\n* Intervar\n\n#### Conditions\n* \"transcript_consequence_terms\" is a missense variant.\n* \"gene_symbol\" is in BP1 gene list.\n\n#### Shortcomings\n\n### BP2\n* Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern\n\n#### Status\n* Planned for trio.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BP3\n* In-frame\u2002deletions/insertions\u2002in\u2002a\u2002repetitive\u2002region\u2002without\u2002a\u2002known\u2002function\n\n#### Status\n* Not Checked.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BP4\n* Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.)\n\n#### Status\n* Implemented\n\n#### Resources\n* VEP\n\n#### Conditions\n* \"sift_score\" greater than or equals to 0.05\n* \"polyphen_score\" less than or equals to 0.446\n\n#### Shortcomings\n\n### BP5\n* Variant found in a case with an alternate molecular basis for disease\n\n#### Status\n* Not Checked.\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n### BP6\n* Reputable source recently reports variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation\n\n#### Status\n* Implemented\n\n#### Resources\n* Clinvar\n\n#### Conditions\n* \"clinical_significance\" is benign\n\n#### Shortcomings\n\n### BP7\n* A synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved\n\n#### Status\n* Planned\n\n#### Resources\n\n#### Conditions\n\n#### Shortcomings\n\n\n", "description_content_type": "", "docs_url": null, "download_url": "", "downloads": {"last_day": -1, "last_month": -1, "last_week": -1}, "home_page": "", "keywords": "genomics next generation sequencing variant classification human genetics", "license": "", "maintainer": "", "maintainer_email": "", "name": "picus", "package_url": "https://pypi.org/project/picus/", "platform": "", "project_url": "https://pypi.org/project/picus/", "project_urls": null, "release_url": "https://pypi.org/project/picus/0.0.4/", "requires_dist": ["pandas"], "requires_python": "", "summary": "Pointed Interpretation of Clinical Variant Significance", "version": "0.0.4", "yanked": false, "html_description": "<div class=\"project-description\">\n            <p># Picus\nPointed Interpretation of Clinical Variant Significance</p>\n<p>## Quick Install\n* Linux&amp;Mac</p>\n<p>&gt; sudo pip3 install picus</p>\n<ul>\n<li>Windows</li>\n</ul>\n<p>&gt; pip install picus</p>\n<p>## Example Uses</p>\n<ul>\n<li>Picus examples</li>\n</ul>\n<p>&gt; picus -i input.csv -o output.json</p>\n<p>## Evidence Collection Process</p>\n<p>### PVS1\n* PVS1 null variant (nonsense, frameshift, canonical \u00b11 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease.</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* LoF genes list from intervar. <a href=\"https://raw.githubusercontent.com/barslmn/InterVar/master/intervardb/PVS1.LOF.genes.hg19\" rel=\"nofollow\">https://raw.githubusercontent.com/barslmn/InterVar/master/intervardb/PVS1.LOF.genes.hg19</a>\n* Null variants defined as HIGH IMPACT by <a href=\"https://www.ensembl.org/info/genome/variation/prediction/predicted_data.html\" rel=\"nofollow\">https://www.ensembl.org/info/genome/variation/prediction/predicted_data.html</a></p>\n<p>#### Conditions\n* \u201cgene_symbol\u201d is in LoF gene list.\n* \u201ctranscript_consequence_terms\u201d is high impact.</p>\n<p>#### Shortcomings\n* LoF gene list is only predictive and may be missing some actual LoF genes.\n* No checks for multiexon deletion.</p>\n<p>### PS1\n* Same amino acid change as a previously established pathogenic variant regardless of nucleotide change.</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* Clinvar xml (<a>ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/</a>)</p>\n<p>#### Annotation Steps\n1. Clinvar data is parsed using <a href=\"https://github.com/barslmn/clinvar\" rel=\"nofollow\">https://github.com/barslmn/clinvar</a>.\n2. Sample data and clinvar data is merged based on columns \u201cCHR\u201d and \u201cPOS\u201d.\n3. Clinvar feature columns \u201cALT\u201d, \u201chgvsp\u201d, and \u201cclinical_significance\u201d added to original annotation.</p>\n<p>#### Conditions\n1. \u201cclinical_significance\u201d is pathogenic.\n2. Sample \u201chgvsp\u201d and later added clinvar \u201chgvsp\u201d changes are the same.\n3. Sample \u201cALT\u201d and clinvar \u201cALT\u201d are different.</p>\n<p>#### Shortcomings</p>\n<p>### PS2\n* De novo (both maternity and paternity confirmed) in a patient with the disease and no family history.</p>\n<p>#### Status\n* Not Checked</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PS3\n* Well-established\u2002in\u2002vitro\u2002or\u2002in\u2002vivo\u2002functional\u2002studies\u2002supportive\u2002of\u2002a\u2002damaging\u2002effect\u2002on\u2002the\u2002gene\u2002or\u2002gene\u2002product</p>\n<p>#### Status\n* Not Checked</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PS4\n* The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* Intervar</p>\n<p>#### Conditions\n1. \u201cid\u201d is in id list.</p>\n<p>#### Shortcomings\n1. No idea how the source is made.</p>\n<p>### PM1\n* Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation</p>\n<p>#### Status\n* Planned.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PM2\n* Absent from controls (or at extremely low frequency if recessive) (Table 6) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* VEP</p>\n<p>#### Conditions\n* \u201cgnomad\u201d less than 0.001.</p>\n<p>#### Shortcomings</p>\n<p>### PM3\n* For\u2002recessive\u2002disorders,\u2002detected\u2002in\u2002trans with a pathogenic variant</p>\n<p>#### Status\n* Planned for trio</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PM4\n* Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* VEP</p>\n<p>#### Conditions\n* \u201ctranscript_consequence_terms\u201d is \u201cinframe_insertion\u201d, \u201cinframe_deletion\u201d, or \u201cstop_lost\u201d.</p>\n<p>#### Shortcomings\n* No checks for repeat regions.</p>\n<p>### PM5\n* Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before</p>\n<p>#### Status\n* Broken. (\u256f\u00b0\u25a1\u00b0\uff09\u256f\ufe35 \u253b\u2501\u253b)</p>\n<p>#### Resources\n* Clinvar xml (<a>ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/</a>)</p>\n<p>#### Annotation Steps\n1. Clinvar data is parsed using <a href=\"https://github.com/barslmn/clinvar\" rel=\"nofollow\">https://github.com/barslmn/clinvar</a>.\n2. Sample data and clinvar data hgvsp columns parsed till position.\n3. Synonym changes removed from clinvar data.\n4. Clinvar feature columns \u201chgvsc\u201d, and \u201cclinical_significance\u201d added to original annotation based on protein change position.</p>\n<p>#### Conditions\n1. \u201cgnomad\u201d less then 0.001.\n2. \u201cclinical_significance\u201d is pathogenic.\n3. \u201ctranscript_consequence_terms\u201d is missense variant.\n4. \u201chgvsc\u201d of the variant and clinvar entry dont match.</p>\n<p>#### Shortcomings</p>\n<p>### PM6\n* Assumed de novo, but without confirmation of paternity and maternity</p>\n<p>#### Status\n* Planned for trio.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PP1\n* Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease</p>\n<p>#### Status\n* Planned after Vesta.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PP2\n* Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* Intervar</p>\n<p>#### Conditions\n* \u201ctranscript_consequence_terms\u201d is a missense variant.\n* \u201cgene_symbol\u201d is in PP2 gene list.</p>\n<p>#### Shortcomings</p>\n<p>### PP3\n* Multiple\u2002lines\u2002of\u2002computational\u2002evidence\u2002support\u2002a\u2002deleterious\u2002effect\u2002on\u2002the\u2002gene\u2002or\u2002gene\u2002product\u2002(conservation, evolutionary, splicing impact, etc.)</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* Vep</p>\n<p>#### Conditions\n* \u201csift_score\u201d less than 0.05\n* \u201cpolyphen_score\u201d greater than 0.908</p>\n<p>#### Shortcomings</p>\n<p>### PP4\n* Patient\u2019s phenotype or family history is highly specific for a disease with a single genetic etiology</p>\n<p>#### Status\n* Not Checked.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### PP5\n* Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation</p>\n<p>#### Status\n* Implemented.</p>\n<p>#### Resources\n* Clinvar</p>\n<p>#### Conditions\n* \u201cclinical_significance\u201d is Pathogenic.</p>\n<p>#### Shortcomings</p>\n<p>### Benign</p>\n<p>### BA1\n* Allele frequency is &gt;5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium</p>\n<p>#### Status\n* Implemented.</p>\n<p>#### Resources\n* Vep</p>\n<p>#### Conditions\n* \u201cminor_allele_freq\u201d is greater than 0.05</p>\n<p>OR</p>\n<ul>\n<li>\u201cgnomad\u201d is greater than 0.05.</li>\n</ul>\n<p>#### Shortcomings</p>\n<p>### BS1\n* Allele frequency is greater than expected for disorder</p>\n<p>#### Status\n* Planned for later.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BS2\n* Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age</p>\n<p>#### Status\n* Planned</p>\n<p>#### Resources\n* Intervar</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BS3\n* Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing</p>\n<p>#### Status\n* Not Checked.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BS4\n* Lack of segregation in affected members of a family</p>\n<p>#### Status\n* Not Checked.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BP1\n* Missense variant in a gene for which primarily truncating variants are known to cause disease</p>\n<p>#### Status\n* Implemented.</p>\n<p>#### Resources\n* Intervar</p>\n<p>#### Conditions\n* \u201ctranscript_consequence_terms\u201d is a missense variant.\n* \u201cgene_symbol\u201d is in BP1 gene list.</p>\n<p>#### Shortcomings</p>\n<p>### BP2\n* Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern</p>\n<p>#### Status\n* Planned for trio.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BP3\n* In-frame\u2002deletions/insertions\u2002in\u2002a\u2002repetitive\u2002region\u2002without\u2002a\u2002known\u2002function</p>\n<p>#### Status\n* Not Checked.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BP4\n* Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.)</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* VEP</p>\n<p>#### Conditions\n* \u201csift_score\u201d greater than or equals to 0.05\n* \u201cpolyphen_score\u201d less than or equals to 0.446</p>\n<p>#### Shortcomings</p>\n<p>### BP5\n* Variant found in a case with an alternate molecular basis for disease</p>\n<p>#### Status\n* Not Checked.</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n<p>### BP6\n* Reputable source recently reports variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation</p>\n<p>#### Status\n* Implemented</p>\n<p>#### Resources\n* Clinvar</p>\n<p>#### Conditions\n* \u201cclinical_significance\u201d is benign</p>\n<p>#### Shortcomings</p>\n<p>### BP7\n* A synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved</p>\n<p>#### Status\n* Planned</p>\n<p>#### Resources</p>\n<p>#### Conditions</p>\n<p>#### Shortcomings</p>\n\n          </div>"}, "last_serial": 5041131, "releases": {"0.0.1": [{"comment_text": "", "digests": {"md5": "c09b1ffa484660c1120606875f5348b9", "sha256": "531d94fa09ab32d80b8f2375b2aef6bdd3059d955b78a192379e4c5530932b34"}, "downloads": -1, "filename": "picus-0.0.1-py3-none-any.whl", "has_sig": false, "md5_digest": "c09b1ffa484660c1120606875f5348b9", "packagetype": "bdist_wheel", "python_version": "py3", "requires_python": null, "size": 7780, "upload_time": "2019-03-08T09:50:41", "upload_time_iso_8601": "2019-03-08T09:50:41.850529Z", "url": "https://files.pythonhosted.org/packages/a0/3c/c2c10e225a71f3e4f2d4b7007f38d55b4da109f92ab2bca8cdd849bf71f6/picus-0.0.1-py3-none-any.whl", "yanked": false}], "0.0.2": [{"comment_text": "", "digests": {"md5": "499d63c832e622c6de8710f649d492c3", "sha256": "a1fe5db3ce4f08e68badef76b6cc0d3754fd6bc2961c277d38436fd43d76d9a9"}, "downloads": -1, "filename": "picus-0.0.2-py3-none-any.whl", "has_sig": false, "md5_digest": "499d63c832e622c6de8710f649d492c3", "packagetype": "bdist_wheel", "python_version": "py3", "requires_python": null, "size": 6829112, "upload_time": "2019-03-29T10:09:08", "upload_time_iso_8601": "2019-03-29T10:09:08.629867Z", "url": "https://files.pythonhosted.org/packages/d6/80/d16ba152988a2fda22c40fe5c6ddfeee9ac8a5b234bae7a20e51aee2e307/picus-0.0.2-py3-none-any.whl", "yanked": false}], "0.0.3": [{"comment_text": "", "digests": {"md5": "35eebd905826d69180755cd96bcf182b", "sha256": "f8eb1850cd84d0c062264f5955e6569423edd1689647378dd0d208ee44726819"}, "downloads": -1, "filename": "picus-0.0.3-py3-none-any.whl", "has_sig": false, "md5_digest": "35eebd905826d69180755cd96bcf182b", "packagetype": "bdist_wheel", "python_version": "py3", "requires_python": null, "size": 6833593, "upload_time": "2019-04-01T08:53:42", "upload_time_iso_8601": "2019-04-01T08:53:42.199443Z", "url": "https://files.pythonhosted.org/packages/b1/96/1b179f17004a82aa2f973ff4ba3ce730d9b459cf9e1ffb13b287e617342a/picus-0.0.3-py3-none-any.whl", "yanked": false}], "0.0.4": [{"comment_text": "", "digests": {"md5": "c95bf12e4d1056b58c03895d0bad10f5", "sha256": "7f1ca52c5f29d240d215e50190c97d60f309d04cb961b44528faeb2b5ca02743"}, "downloads": -1, "filename": "picus-0.0.4-py3-none-any.whl", "has_sig": false, "md5_digest": "c95bf12e4d1056b58c03895d0bad10f5", "packagetype": "bdist_wheel", "python_version": "py3", "requires_python": null, "size": 6833809, "upload_time": "2019-04-01T21:45:05", "upload_time_iso_8601": "2019-04-01T21:45:05.122223Z", "url": "https://files.pythonhosted.org/packages/08/d3/0cd7c07d6073b5ec0b2f1a4dcd24c8078d815e41ed7c6a5428f466c9591e/picus-0.0.4-py3-none-any.whl", "yanked": false}]}, "urls": [{"comment_text": "", "digests": {"md5": "c95bf12e4d1056b58c03895d0bad10f5", "sha256": "7f1ca52c5f29d240d215e50190c97d60f309d04cb961b44528faeb2b5ca02743"}, "downloads": -1, "filename": "picus-0.0.4-py3-none-any.whl", "has_sig": false, "md5_digest": "c95bf12e4d1056b58c03895d0bad10f5", "packagetype": "bdist_wheel", "python_version": "py3", "requires_python": null, "size": 6833809, "upload_time": "2019-04-01T21:45:05", "upload_time_iso_8601": "2019-04-01T21:45:05.122223Z", "url": "https://files.pythonhosted.org/packages/08/d3/0cd7c07d6073b5ec0b2f1a4dcd24c8078d815e41ed7c6a5428f466c9591e/picus-0.0.4-py3-none-any.whl", "yanked": false}], "timestamp": "Fri May  8 02:54:58 2020"}